Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Orelabrutinib Tablets

Obtunib tablets are indicated for the following treatments:
Adult mantle cell lymphoma (MCL) patients who have received at least one previous treatment.
Adult chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients who have received at least one previous treatment.
This product is a selective Bruton’s tyrosine kinase (BTK) inhibitor that can inhibit the activation of BTK-related signaling pathways and inhibit the overactivation and proliferation of B cells.

Brand: pill Categories:

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.